Open access · OA
via OpenAlex
β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes
Laura I. Hudish, Jane E.B. Reusch, Lori Sussel
Journal of Clinical Investigation · 2019 · ▲ 336 citations
Abstract
In a society where physical activity is limited and food supply is abundant, metabolic diseases are becoming a serious epidemic. Metabolic syndrome (MetS) represents a cluster of metabolically related symptoms such as obesity, hypertension, dyslipidemia, and carbohydrate intolerance, and significantly increases type 2 diabetes mellitus risk. Insulin resistance and hyperinsulinemia are consistent characteristics of MetS, but which of these features is the initiating insult is still widely debated. Regardless, both of these conditions trigger adverse responses from the pancreatic β cell, which is responsible for producing, storing, and releasing insulin to maintain glucose homeostasis. The observation that the degree of β cell dysfunction correlates with the severity of MetS highlights the need to better understand β cell dysfunction in the development of MetS. This Review focuses on the current understanding from rodent and human studies of the progression of β cell responses during the development of MetS, as well as recent findings addressing the complexity of β cell identity and heterogeneity within the islet during disease progression. The differential responses observed in β cells together with the heterogeneity in disease phenotypes within the patient population emphasize the need to better understand the mechanisms behind β cell adaptation, identity, and dysfunction in MetS.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1172/jci129188
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Hudish, L.I., Reusch, J.E., & Sussel, L. (2019). β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes. <em>Journal of Clinical Investigation</em>. https://doi.org/10.1172/jci129188
Vancouver
Hudish LI, Reusch JE, Sussel L. β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes. Journal of Clinical Investigation. 2019. doi:10.1172/jci129188.
BibTeX
@article{laura2019Celldy,
title = {β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes},
author = {Laura I. Hudish and Jane E.B. Reusch and Lori Sussel},
journal = {Journal of Clinical Investigation},
year = {2019},
doi = {10.1172/jci129188},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PubMed 2006
Preprint
Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
Archives of Internal Medicine 2006
Citation only
Metabolic Syndrome Compared With Type 2 Diabetes Mellitus as a Risk Factor for Stroke
Diabetologia 2005
Open access · OA
Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes
Journal of Biosciences and Medicines 2023
Open access · CC-BY
Prevalence of Metabolic Syndrome in People with Type 2 Diabetes in Romania
Frontiers in Endocrinology 2018
Open access · CC-BY
mTORC1 Overactivation as a Key Aging Factor in the Progression to Type 2 Diabetes Mellitus
Circulation 2011
Open access · OA